Spelling suggestions: "subject:"microvascular complications"" "subject:"microvasculars complications""
1 |
INVESTIGATING THE EFFECTS OF HYPERGLYCEMIA ON THE VASA VASORUM IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND ESTABLISHMENT OF NOVEL MOUSE MODELS OF DIABETES / Effects of Hyperglycemia in Mouse Models of AtherosclerosisVenegas Pino, Daniel January 2016 (has links)
The prevalence of diabetes is increasing rapidly around the world. People with diabetes are 2–4 times more likely to die from cerebro and cardio-vascular causes than people with no history of diabetes, even after controlling for other risk factors. Atherosclerosis, the underlying cause of most cardiovascular disease (CVD), is accelerated in people with diabetes, but several clinical trials have questioned the efficacy of glucose lowering therapies. A better understanding of the molecular pathways by which diabetes accelerates atherosclerosis will expand the scope of current targets and strategies for more effective therapies. In this thesis we investigate a novel mechanism and establish and characterize new hyperglycemic mouse models for the study of diabetic atherosclerosis.
Firstly, we investigate the effects of hyperglycemia on the vasa vasorum, the microvascular network that surrounds and supplies large vessels, and correlate those effects to the development of atherosclerosis. In normoglycemic ApoE-/- mice, the vasa vasorum expands as atherosclerotic lesions grow. However, in hyperglycemic ApoE-/- mice there is no significant neovascularization of the vasa vasorum despite the enhanced atherosclerotic development. We hypothesize that the ability of hyperglycemia to disrupt vasa vasorum neovascularization may promote the development and progression of atherosclerosis in diabetes.
Secondly, we establish, characterize and manipulate a new model of hyperglycemia-induced atherosclerosis: the ApoE-/-:Ins2+/Akita mouse. We describe sex-specific differences of the ApoE-/-:Ins2+/Akita mouse model. Male ApoE-/-:Ins2+/Akita mice develop chronic hyperglycemia and accelerated atherosclerosis. Castration slows atherosclerosis in ApoE-/-:Ins2+/Akita mice but enhances it in normoglycemic controls. Female ApoE-/-:Ins2+/Akita mice are only transiently hyperglycemic but still present with accelerated atherosclerosis. Ovariectomized ApoE-/-:Ins2+/Akita mice are chronically hyperglycemic and show indications of advanced atherosclerosis.
Lastly, we investigate the effects of a western-type diet on the hyperglycemic ApoE-/-:Ins2+/Akita mice. We demonstrate the pernicious phenotype of the mice leading to a significantly shortened lifespan correlated with massive atherosclerosis that extends to the aortic sinus, ascending and descending aorta, brachiocephalic artery and coronary arteries.
In conclusion we provide insights for a new mechanism by which hyperglycemia may accelerate atherosclerosis and possible role of the vasa vasorum in the progression of atherosclerosis in hyperglycemic mice. We also establish new mouse models that illuminate the action of sex hormones on pancreatic beta-cell function and the vasculature. These models will provide a test bed to further study sex hormone effects, as well as the diabetic pathways that promote atherosclerosis. / Thesis / Doctor of Philosophy (PhD)
|
2 |
Biomarkery v diagnostice a terapii pozdních komplikací diabetu. / Biomarkers in the diagnosis and treatment of diabetic complicationsŠoupal, Jan January 2017 (has links)
The main objective of this study was research on biomarkers used in both diagnosis and therapy of diabetic complications. The main focus of our work came to be on one of these biomarkers - glycemic variability (GV). High GV is linked with more frequent occurance of hypoglycemia. There are even indications it might contribute to development of diabetic complications. With modern technology - continuous glucose monitoring (CGM), we are now able to reliably describe, calculate and reduce GV. So far it is unclear whether increased GV can contribute to the development of microvascular complications (MVC) in type 1 diabetes (T1D). Studies published so far have assessed GV primarily from routine self-monitoring of blood glucose (SMBG) using glucometers. In the light of this uncertaity, the first part of this work compares GV calculated from CGM with the presence of MVC in T1D patients. GV calculated from CGM, but not from SMBG, proved to be significantly higher in T1D patients with MVC, even though there was no significant difference in glycated hemoglobin (HbA1c). This finding supports the hypothesis that higher GV is related to higher risk of MVC and that HbA1c does not describe diabetes control completely. Moreover, it was shown that GV calculated from SMBG is insufficient. There is still no fully...
|
3 |
Vztah oxidačního stresu k parametrům kompenzace diabetu při rozvoji cévních komplikací. / Relationship of oxidative stress to parameters of diabetes control in development of vascular complications.Pelcl, Tomáš January 2020 (has links)
The aim of this thesis is to contribute to the clarification of the pathogenesis of chronic complications of diabetes mellitus. The main goal of the research was glycaemic variability, its contribution to the activation of oxidative stress and its possible role in the process of advanced glycation, all beyond the scope of persistent hyperglycaemia itself. Another aim of the work is to contribute to the clarification of a possible relationship between glycaemic variability and vascular complications of diabetes. We were the first to describe the association between the concentrations of reactive aldehydes formed during lipid peroxidation and disorders of skin microvascular reactivity in patients with type 1 diabetes (DM1). Elevated markers of oxidative stress were found in this group, furthermore during the 3 years of follow-up higher plasma antioxidant activity was observed. These findings were not dependent of the method of glucose monitoring and glucose variability, which was lower in a subgroup of patients using real-time continuous glucose monitoring (rt-CGM), compared to a subgroup using conventional glucometers. However, it is clear, that hyperglycaemia alone induces increased oxidative stress in patients with diabetes. Simultaneously we observed the opposite process of oxidative stress...
|
4 |
Dano ao DNA no diabetes tipo 2 e sua associação com inflamação, estresse oxidativo, disfunção endotelial, resistência à insulina e à ocorrência de complicações crônicas microvasculares / DNA damage in type 2 diabetes and its association with inflammation, oxidative stress, endothelial dysfunction, insulin resistance and the occurrence of microvascular chronic complicationsTatsch, Etiane 15 March 2016 (has links)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Several pathophysiological mechanisms are associated with type 2 diabetes mellitus (type 2 DM), such as glucotoxicity, insulin resistance, inflammation, oxidative stress and endothelial dysfunction, which can result in DNA strand breakage and changes in the nitrogenous bases. In this manner, DNA damage biomarkers may be useful in elucidating the pathophysiology of diabetes, as well as serving as an alternative to better evaluate its chronic complications. However, a great number of pathophysiological mechanisms related to increased DNA damage in diabetes need to be clarified. Thus, the objective of this study was to evaluate DNA damage in type 2 diabetes and its association with inflammation, oxidative stress, endothelial dysfunction, resistance towards insulin and the occurrence of chronic microvascular complications. The DNA damage was evaluated through the comet assay and the levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG) urinary, the inflammatory process through the serum levels of interleukin (IL) 1, 6 and 10 and the alpha tumor necrosis factor (TNF-α), protein oxidation through plasma levels of advanced oxidation protein products (AOPPs), endothelial dysfunction by serum levels of NOx (nitrite/nitrate) and urinary albumin and insulin resistance through the index HOMA-IR. The present study was carried out in two phases. In the first phase, 32 patients with type 2 DM and 30 healthy individuals (control) were investigated. In the second phase, 54 patients with type 2 DM and 22 healthy individuals (control) were recruited from the University Hospital of Santa Maria (HUSM). This study found that patients with type 2 diabetes showed increased DNA fragmentation, assessed by comet assay, and increased oxidative DNA damage, assessed by 8-hydroxy-2'-deoxyguanosine (8-OhdG) urinary levels, compared to healthy control subjects. Additionally, increased DNA damage was observed in the type 2 DM group with inadequate glycemic control. When the areas obtained under the ROC curve were analyzed, 8-OHdG urinary presented higher diagnostic ability in identifying microvascular chronic complications compared with urinary albumin in the type 2 DM group. Furthermore, it was demonstrated that type 2 diabetic patients with microvascular complications had higher levels of oxidative DNA damage compared to patients without such complications. Interestingly enough, it was observed that type 2 diabetic patients with increased DNA damage had higher levels of proinflammatory cytokines such as IL-1, IL-6 and TNF-α, and a decrease in IL-10 levels, which is considered an anti-inflammatory cytokine. An association between increased DNA damage in type 2 diabetes and the index HOMA-IR, AOPPs levels and NOx levels and urinary albumin was also verified. Patients with type 2 diabetes exhibited factors that can directly contribute to the increase of DNA damage, such as insulin resistance, inflammation, endothelial dysfunction and increased generation of reactive species. / Diversos mecanismos fisiopatológicos estão associados ao Diabetes Mellitus (DM) tipo 2, como glicotoxicidade, resistência à insulina, inflamação, estresse oxidativo e disfunção endotelial, podendo resultar em quebras nos filamentos de DNA e modificações nas bases nitrogenadas. Desta maneira, biomarcadores de dano ao DNA podem ser úteis na elucidação da fisiopatologia do DM, bem como uma alternativa para a melhor avaliação de suas complicações crônicas. No entanto, muitos destes mecanismos fisiopatológicos relacionados ao aumento do dano ao DNA no diabetes precisam ser esclarecidos. Assim, o objetivo deste estudo foi avaliar o dano ao DNA no DM tipo 2 e sua associação com inflamação, oxidação proteica, disfunção endotelial, resistência à insulina e à ocorrência de complicações crônicas microvasculares. O dano ao DNA foi avaliado através do ensaio cometa e dos níveis de 8-hidroxi-2'-desoxiguanosina (8-OHdG) urinário, o processo inflamatório através dos níveis séricos das interleucinas (IL) 1, 6 e 10 e do fator de necrose tumoral alfa (TNF-α) , a oxidação proteica através dos níveis plasmáticos dos produtos proteicos de oxidação avançada (AOPPs), a disfunção endotelial através dos níveis séricos de NOx (nitrito/nitrato) e albumina urinária e a resistência insulínica através do índice HOMA-IR. O presente estudo foi conduzido em duas fases. Na primeira fase 32 pacientes com DM tipo 2 e 30 controles saudáveis foram investigados. Na segunda fase 54 pacientes com DM tipo 2 e 22 indivíduos controle foram recrutados no Hospital Universitário de Santa Maria (HUSM). Neste estudo, foi verificado que os pacientes com DM tipo 2 apresentaram aumento na fragmentação do DNA, avaliado pelo ensaio cometa, e um maior dano oxidativo ao DNA, avaliado pelos níveis urinários de 8-OHdG, comparados com indivíduos controles saudáveis. Também foi verificado no grupo DM tipo 2 com controle glicêmico inadequado um maior dano ao DNA. Quando foram analisadas as áreas sob a curva ROC obtidas, verificamos que o 8-OHdG urinário apresentou uma maior capacidade diagnóstica em identificar as complicações crônicas microvasculares, quando comparada com a albumina urinária no grupo DM tipo 2. Além disso, foi demonstrado que os pacientes diabéticos tipo 2 com complicações microvasculares apresentaram maiores níveis de dano oxidativo ao DNA, comparado aos pacientes que não apresentavam estas complicações. Interessantemente, foi observado que os pacientes DM tipo 2 com maior dano ao DNA apresentaram maiores níveis de citocinas pró-inflamatórias, como IL-1, IL-6 e TNF-α, além de um decréscimo nos níveis de IL-10, considerada um citocina anti-inflamatória. Também foi verificada uma associação entre o aumento do dano ao DNA no DM tipo 2 e o índice HOMA-IR, os níveis de AOPPs e os níveis de NOx e albumina urinária. Desta forma, nós especulamos que os pacientes com DM tipo 2 apresentaram uma cascata de eventos como, resistência à insulina, processo inflamatório, disfunção endotelial e aumento da geração de espécies reativas, fatores que podem contribuir diretamente para o aumento do dano ao DNA.
|
5 |
Évaluation de nouvelles méthodes de prédiction et de dépistage précoce de l’albuminurie chez les patients avec diabète de type 2Santucci, Lara 12 1900 (has links)
Le diabète de type 2 (DT2) est une maladie chronique grave et sa prévalence ne cesse d’augmenter partout dans le monde. La complication la plus sévère et la plus courante du diabète est la néphropathie diabétique dont le premier symptôme est l’albuminurie. Notre premier objectif est d’évaluer si un dépistage précoce de l’albuminurie permet une meilleure prise en charge de cette complication dans la pratique générale des médecins. Notre deuxième objectif est de valider l’efficacité de notre score de risque polygénique (SRP) sur la prédiction du risque d’albuminurie sur une cohorte canadienne composée de patients DT2, hypertendus provenant de groupe de médecine familiale (GMF) et de family health team (FHT) au Québec et en Ontario (CLINPRADIA I). Le SRP a permis de déterminer les 30% de patients à risque élevé de développer l’albuminurie. En effet, la prévalence d’albuminurie des 30% des sujets classés à haut risque génétique par le SRP était 2,6 fois plus élevée que le reste des patients de CLINPRADIA I. Dans la même cohorte, nous avons démontré que l’introduction d’un point of care testing (POCT) a amélioré la pratique et l’adhésion des médecins aux lignes directrices du traitement de l’albuminurie. Les valeurs d’albuminurie et le nombre de patients albuminuriques ont diminué significativement en réponse à l’introduction du POCT. Nous pouvons conclure de nos résultats que l’utilisation de notre SRP permettrait d’identifier les patients à risque élevés d’albuminurie alors que le POCT permettrait un dépistage précoce et un meilleur suivi de l’albuminurie chez ces patients. / Type 2 diabetes (T2D) is a serious chronic disease and its prevalence keeps increasing all over the world. The most severe and common diabetes complication is nephropathy of which the first symptom is albuminuria. Our first objective is to evaluate if early screening of albuminuria allows for a better patient care of this condition in general practitioner practice. Our second objective is to validate the efficacy of our polygenetic risk score (PRS) on the risk prediction of albuminuria on Canadian cohort composed of hypertensive TD2 patients from groupe de médecine familiale (GMF) and family health team (FHT) in Quebec and in Ontario (CLINPRADIA I). The PRS identified the 30% of T2D patients at high risk of developing albuminuria. Indeed, the albuminuria prevalence of the 30% of subjects at high genetic risk based on the PRS was 2.6 times higher than the remaining patients of CLINPRADIA I. In the same cohort, we established that the introduction of the point of care testing (POCT) improves the practice and the adherence of physicians to the guidelines for the treatment of albuminuria. The values of albuminuria and the number of patients with albuminuria decreased significantly after the introduction of the POCT. We can conclude from our results that the use of our PRS enables the early identification of the patients at high risk of albuminuria while the POCT enables the early detection of patients with albuminuria who benefited from an early intervention.
|
6 |
Clinical studies in diabetic vasculopathy to assess interactions between blood, bone and kidneySingh, Dhruvaraj Kailashnath January 2010 (has links)
Diabetic vasculopathy (DV) is the most important consequence of chronic hyperglycemia in patients with diabetes mellitus (DM). This thesis explores the interaction of blood, bone and kidney in the pathogenesis of DV by i) reviewing the current understanding of pathogenesis of macrovascular and microvascular diseases in DM to identify gaps in literature and generate hypotheses relating to various facets of DV ii) undertaking a series of prospective studies to examine these hypotheses iii) analysing the findings and integrating any new information obtained from the clinical studies into the current knowledge base and iv) generating hypotheses upon which future work might be based. The literature search was carried out with the aim of understanding current concepts of pathogenesis of DV and its potential modulators. The original reviews resulting from this process are presented in chapters 2 to 4. A series of pilot studies reported in chapters 7 to 11, were then carried out to interrogate hypotheses originating from this process. The first study was carried out in healthy individuals to define the biological variation of potential modulators of DV, namely erythropoietin (EPO), parathyroid hormone, 25 hydroxyvitamin D and 1, 25-dihydroxyvitamin D to facilitate the design and interpretation of subsequent studies. It revealed a wide biological variation of these modulators in the healthy population thus,emphasizing the need to have a control group in the subsequent study population. To examine whether tubulointerstitial dysfunction occurs before the onset of microalbuminuria, a measurement of the above mentioned parameters was carried out along with markers of tubulointerstitial injury in patients with type 1 and type 2 DM without microalbuminuria and in non-diabetic controls. It was found that tubulointerstitial dysfunction with low levels of EPO and 1, 25-dihydroxyvitamin D and higher excretion of tubular injury markers, occurs before the onset of microalbuminuria. Subsequently, diabetic and nondiabetic chronic kidney disease (CKD) patients with EPO deficiency anaemia were examined to study the effects of EPO therapy on the excretion of tubular injury markers. However, in these patient groups, we were unable to demonstrate an effect of EPO therapy on the markers of tubular injury in spite of a beneficial haematological response. To examine whether vascular calcification (VC) and bone mineral density (BMD) were linked in patients with diabetes mellitus and to explore their relationship to modulators of DV, an assessment of VC and BMD was undertaken in patients with type 2 DM with different degrees of proteinuria and normoalbuminuria. VC was assessed by CT scan and BMD by a DEXA scan. Modulators of DV were measured including serum Osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-b-ligand (RANKL). The findings were i) a high prevalence of VC and osteopenia in normoalbuminuric type 2 DM patients with normal serum creatinine ii) a weak inverse relationship between VC and osteopenia iii) proteinuric patients had worse VC but not osteopenia iv) weak relationships between OPG levels and both VC and osteopenia, masked by age in multivariate analysis. The final study examined the relationship between modulators of DV, including OPG and RANKL, and the degree of CKD. It was found that abnormalities of OPG and RANKL occur before the onset of microalbuminuria and progress with deterioration of renal function. Compared to nondiabetics, DM patients have higher OPG levels in the predialysis phase and lower levels in haemodialysis phase, a phenomenon that might indicate endothelial exhaustion in dialysis patients with DM. The derangements associated with DV seem to occur earlier than previously thought. Further work is required to untangle these complexities and to define the contribution of factors such as the adverse blood milieu, the vasculature, abnormal bone and mineral metabolism, and early tubulointerstitial damage. The findings from the studies reported here may help in the formulation of new hypotheses, which might contribute to future work in this area.
|
7 |
Η συσχέτιση των τελικών προϊόντων προχωρημένης γλυκοζυλίωσης (AGEs), του υποδοχέα τους (RAGE) και του διαλυτού τμήματός του (sRAGE) σε παιδιά, εφήβους και νεαρούς ενήλικες με σακχαρώδη διαβήτη τύπου 1 (ΣΔ1) / Association between advanced glycation endproducts (AGEs), their receptor (RAGE) and its soluble isoform (sRAGE) in children, adolescents and young adults with diabetes mellitus type 1Δεττοράκη, Αθηνά 30 May 2012 (has links)
Τα τελικά προϊόντα προχωρημένης γλυκοζυλίωσης (AGEs: Advanced Glycation Endproducts) παίζουν σημαντικό ρόλο στην παθογένεια των διαβητικών αγγειακών επιπλοκών. Το καλύτερα χαρακτηριζόμενο είναι η N-καρβοξυμεθυλ-λυσίνη (CML). Τα AGEs προκαλούν σημαντικές επιδράσεις στα αγγεία με την πρόσδεσή τους σε ειδικούς υποδοχείς της κυτταρικής επιφάνειας, όπως τον RAGE (Receptor for Advanced Glycation Endproducts). Διαλυτές μορφές του RAGE (sRAGE) εμφανίζονται στο ανθρώπινο αίμα και δρουν ως παγίδα αιχμαλωτίζοντας τους φλεγμονώδεις προσδέτες του RAGE εξωκυττάρια, προστατεύοντας με αυτό τον τρόπο τα κύτταρα από τη βλάβη που προάγεται από τα AGEs.
Σκοπός αυτής της εργασίας ήταν να μελετηθούν τα επίπεδα του sRAGE, η πρωτεϊνική έκφραση του RAGE, καθώς και τα επίπεδα CML σε σχέση με διάφορες κλινικές και βιοχημικές παραμέτρους σε παιδιά, εφήβους και νεαρούς ενήλικες με ΣΔ1. Τα επίπεδα sRAGE και CML προσδιορίστηκαν με ELISA και η πρωτεϊνική έκφραση του RAGE στα μονοπύρηνα του περιφερικού αίματος με ανοσοαποτύπωση κατά Western σε 74 παιδιά, εφήβους και νεαρούς ενήλικες με ΣΔ1 (13± 4 χρονών) και 43 μάρτυρες αντίστοιχης ηλικίας, φύλου και σταδίου Tanner.
Σ’ αυτή την εργασία τα αυξημένα επίπεδα sRAGE στα παιδιά με ΣΔ1 και πιο ειδικά, σ’ αυτά ηλικίας κάτω από 13 ετών και με διάρκεια διαβήτη κάτω από 5 έτη, μπορεί να είναι ένα προσωρινό προστατευτικό μέτρο ενάντια στην κυτταρική βλάβη και πιθανόν να είναι επαρκές για να εξουδετερώσει επαρκώς τα κυκλοφορούντα CML, εμποδίζοντας έτσι τις διαβητικές αγγειακές επιπλοκές. Επίσης, μια ήπια αύξηση της LDL θα μπορούσε να είναι ένα ερέθισμα για την αύξηση του sRAGE, οδηγώντας στη δέσμευση του CML και τελικά τη μείωση των επιπέδων CML στην κυκλοφορία. Τα μειωμένα επίπεδα της πρωτεϊνικής έκφρασης του RAGE 55 kd (υποδοχέα πλήρους μήκους) μπορεί να αντανακλούν την αυξημένη έκφραση του sRAGE στους ασθενείς με ΣΔ1 συνολικά λόγω της αποκοπής του RAGE με μεταλλοπρωτεϊνάσες. Με την παρουσία κάποιου παράγοντα κινδύνου, όπως αύξηση ηλικίας, περιμέτρου κοιλίας, BMI, συστολικής ή διαστολικής αρτηριακής πίεσης ή επιδείνωση λιπιδαιμικού προφίλ αυξάνεται η πρωτεϊνική έκφραση της ισομορφής αυτής, ενώ φαίνεται αντίστοιχα να μειώνονται τα επίπεδα του sRAGE. Φαίνεται τελικά ότι συνολικά στα παιδιά, τους εφήβους και τους νεαρούς ενήλικες με ΣΔ1 υπάρχει μια υποκλινική διαταραχή του άξονα sRAGE-RAGE-CML, η οποία δύναται να μετατραπεί σε κλινικά εμφανείς αγγειακές βλάβες, αν προστεθούν περαιτέρω επιβαρυντικοί παράγοντες. / The binding of Advanced Glycation Endproducts (AGEs) to their receptor (RAGE) plays a major role in the development of diabetic vascular complications. This work is based on the relation between circulating soluble RAGE (sRAGE) levels in children, adolescents and young adults with IDDM and RAGE protein expression in association with N-(carboxymethyl)lysine (CML), a major antigenic AGEs component.
Circulating sRAGE and CML levels were determined by ELISA and RAGE protein expression was evaluated in peripheral blood mononuclear cells by western immunoblotting in 74 children, adolescents and young adults with IDDM (134 years old) and 43 age, sex and Tanner stage-matched controls.
Serum sRAGE levels were significantly higher in IDDM than in controls, inversely correlated to diabetes duration and directly correlated to LDL levels. Furthermore, circulating CML levels were not significantly different between IDDM and controls. Also, the protein expression of the RAGE isoforms 55 kd (full-length), 64 kd and 100 kd, measured by western immunoblotting, was significantly lower in IDDM than in controls, whereas RAGE 37 kd levels were not significantly different between IDDM and controls. Finally, when there was a risk factor, such as increased age, poor lipid profile, increased BMI or waist circumference or increased systolic or diastolic pressure, then it seemed that isoforms RAGE 55, 64 and 100 kd were increased. Isoform RAGE 64 kd could be RAGE-v5, a splice variant which resulted in a change of amino acid sequence in the extracellular ligand-binding domain of RAGE. Isoform RAGE 37 kd seemed to be Δ8-RAGE, a soluble splice variant with probably protective function, which had been found increased in patients with increased HDL. Finally, isoform RAGE 100 kd seemed to be some other splice variant in peripheral mononuclear cells.
In conclusion, increased serum levels of sRAGE seen in IDDM children may be a temporary protective measure against cell damage and may be sufficient to efficiently eliminate excessive circulating CML. Moreover, the lower protein expression of the full-length RAGE in IDDM may also reflect the increased sRAGE expression in patients due to RAGE cleavage by metalloproteases. Consequently, in IDDM children, adolescents and young adults there may be a subclinical perturbation of the sRAGE-RAGE-CML axis, which could lead to future clinical vascular damage if additional risk factors are added over time.
|
Page generated in 0.1443 seconds